Literature DB >> 12748061

Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse.

David Q-H Wang1, Susumu Tazuma, David E Cohen, Martin C Carey.   

Abstract

We explored the influence of the hydrophilic-hydrophobic balance of a series of natural bile acids on cholesterol absorption in the mouse. Male C57L/J mice were fed standard chow or chow supplemented with 0.5% cholic; chenodeoxycholic; deoxycholic; dehydrocholic; hyocholic; hyodeoxycholic; alpha-, beta-, or omega-muricholic; ursocholic; or ursodeoxycholic acids for 7 days. Biliary bile salts were measured by reverse-phase HPLC, and hydrophobicity indices were estimated by Heuman's method. Cholesterol absorption efficiency was determined by a plasma dual-isotope ratio method. In mice fed chow, natural proportions of tauro-beta-muricholate (42 +/- 6%) and taurocholate (50 +/- 7%) with a hydrophobicity index of -0.35 +/- 0.04 produced cholesterol absorption of 37 +/- 5%. Because bacterial and especially hepatic biotransformations of specific bile acids occurred, hydrophobicity indices of the resultant bile salt pools differed from fed bile acids. We observed a significant positive correlation between hydrophobicity indices of the bile salt pool and percent cholesterol absorption. The principal mechanism whereby hydrophilic bile acids inhibit cholesterol absorption appears to be diminution of intraluminal micellar cholesterol solubilization. Gene expression of intestinal sterol efflux transporters Abcg5 and Abcg8 was upregulated by feeding cholic acid but not by hydrophilic beta-muricholic acid nor by hydrophobic deoxycholic acid. We conclude that the hydrophobicity of the bile salt pool predicts the effects of individual fed bile acids on intestinal cholesterol absorption. Natural alpha- and beta-muricholic acids are the most powerful inhibitors of cholesterol absorption in mice and might act as potent cholesterol-lowering agents for prevention of cholesterol deposition diseases in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748061     DOI: 10.1152/ajpgi.00156.2003

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  76 in total

1.  Conditional Gata4 deletion in mice induces bile acid absorption in the proximal small intestine.

Authors:  Eva Beuling; Ilona M Kerkhof; Grace A Nicksa; Michael J Giuffrida; Jamie Haywood; Daniel J aan de Kerk; Christina M Piaseckyj; William T Pu; Terry L Buchmiller; Paul A Dawson; Stephen D Krasinski
Journal:  Gut       Date:  2010-07       Impact factor: 23.059

Review 2.  New insights into the molecular mechanism of intestinal fatty acid absorption.

Authors:  Tony Y Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2013-09-18       Impact factor: 4.686

Review 3.  Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs.

Authors:  Tiara R Ahmad; Rebecca A Haeusler
Journal:  Nat Rev Endocrinol       Date:  2019-10-15       Impact factor: 43.330

4.  Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice.

Authors:  Yang Xu; Fei Li; Munaf Zalzala; Jiesi Xu; Frank J Gonzalez; Luciano Adorini; Yoon-Kwang Lee; Liya Yin; Yanqiao Zhang
Journal:  Hepatology       Date:  2016-07-30       Impact factor: 17.425

Review 5.  Targets for current pharmacologic therapy in cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa
Journal:  Gastroenterol Clin North Am       Date:  2010-06       Impact factor: 3.806

6.  Differential regulation of bile acid and cholesterol metabolism by the farnesoid X receptor in Ldlr -/- mice versus hamsters.

Authors:  Christophe Gardès; Evelyne Chaput; Andreas Staempfli; Denise Blum; Hans Richter; G Martin Benson
Journal:  J Lipid Res       Date:  2013-02-21       Impact factor: 5.922

7.  Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice.

Authors:  Katharina Slätis; Mats Gåfvels; Kristina Kannisto; Olga Ovchinnikova; Gabrielle Paulsson-Berne; Paolo Parini; Zhao-Yan Jiang; Gösta Eggertsen
Journal:  J Lipid Res       Date:  2010-07-30       Impact factor: 5.922

8.  Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice.

Authors:  Youcai Zhang; Curtis D Klaassen
Journal:  J Lipid Res       Date:  2010-07-29       Impact factor: 5.922

9.  Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice.

Authors:  Anne S Henkel; Mark H Kavesh; Michael S Kriss; Amanda M Dewey; Mary E Rinella; Richard M Green
Journal:  Gastroenterology       Date:  2011-07-02       Impact factor: 22.682

10.  Cholesterol: from feeding to gene regulation.

Authors:  C Martini; V Pallottini
Journal:  Genes Nutr       Date:  2007-09-27       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.